Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 20 stocks, with a combined market cap of $3.35 trillion, total revenue of $683.95 billion and a weighted average PE ratio of 35.64.

Market Cap
3.35T
Revenue
683.95B
Profits
94.09B
PE Ratio
35.64
Profit Margin
13.76%
Dividend Yield
2.11%

19 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company784.21B0.70%2,334,28245.04B
2JNJJohnson & Johnson384.45B1.13%7,065,57788.82B
3NVONovo Nordisk A/S370.84B0.41%4,756,07540.31B
4ABBVAbbVie Inc.354.62B1.79%3,761,71056.33B
5AZNAstraZeneca PLC227.07B1.02%3,281,62354.07B
6MRKMerck & Co., Inc.221.80B2.43%11,504,47464.17B
7NVSNovartis AG212.12B0.37%1,885,84651.72B
8AMGNAmgen Inc.160.05B1.24%2,318,73933.42B
9PFEPfizer Inc.146.78B0.04%31,794,32963.63B
10GILDGilead Sciences, Inc.137.13B2.21%7,643,58728.75B
11SNYSanofi135.88B0.99%1,129,61745.85B
12BMYBristol-Myers Squibb Company113.22B1.47%6,484,85548.30B
13GSKGSK plc74.62B1.15%6,241,98139.28B
14BIIBBiogen Inc.20.07B0.29%1,987,4249.68B
15GRFSGrifols, S.A.6.11B2.03%409,0807.81B
16OGNOrganon & Co.4.04B2.62%1,915,2316.40B
17AMRNAmarin Corporation plc244.33M0.49%565,263241.02M
18SCLXScilex Holding Company61.48M-4.36%830,72355.15M
19MIRAMIRA Pharmaceuticals, Inc.18.38M-4.31%154,892-